KROS Keros Therapeutics, Inc.

NASDAQ

$11.62

Keros Therapeutics, Inc. (KROS) Earnings News

Earnings press releases, previews and reviews for Keros Therapeutics, Inc. (KROS), newest first.

Monday August 3, 2026 4:01 PM ET

Keros Therapeutics Reports Second Quarter 2026 Financial Results

Thursday May 14, 2026 8:00 AM ET

Keros Therapeutics Reports Recent First Quarter 2026 Financial Results